Clinical Trials Browser

OTHER × Thymoma × Sunitinib × Clear all

NCT03463460 2026-03-23

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Phase 2 Active not recruiting

Thymoma

NCT03449173 2021-06-09

Style

Phase 2 Unknown

Thymoma

NCT02623127 2019-01-23

KOSMIC

Phase 2 Completed

Neoplasm Metastasis, Recurrence, Thymoma